BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6164466)

  • 1. VAB-4 combination chemotherapy in the treatment of metastatic testis tumors.
    Vugrin D; Cvitkovic E; Whitmore WF; Cheng E; Golbey RB
    Cancer; 1981 Mar; 47(5):833-9. PubMed ID: 6164466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis.
    Vugrin D; Whitmore WF; Golbey RB
    Cancer; 1983 Jan; 51(2):211-5. PubMed ID: 6185197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VAB-3 combination chemotherapy of metastatic testicular cancer.
    Reynolds TF; Vugrin D; Cvitkovic E; Cheng E; Braun DW; O'Hehir MA; Dukeman ME; Whitmore WF; Golbey RB
    Cancer; 1981 Aug; 48(4):888-98. PubMed ID: 6168360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis].
    Madej G; Gigier A; Siedlecki P; Pieńkowski T
    Nowotwory; 1987; 37(1):44-9. PubMed ID: 2442730
    [No Abstract]   [Full Text] [Related]  

  • 6. [Total remission of advanced cancer of the testis with the use of the VAB6 schedule: experience with 40 cases].
    Srougi M; Simon SD; de Góes GM
    AMB Rev Assoc Med Bras; 1985; 31(3-4):52-8. PubMed ID: 2417287
    [No Abstract]   [Full Text] [Related]  

  • 7. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
    Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
    J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 9. VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors.
    Vugrin D; Whitmore WF; Golbey RB
    Cancer; 1983 Mar; 51(6):1072-5. PubMed ID: 6185211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VAB-6 as initial treatment of patients with advanced seminoma.
    Stanton GF; Bosl GJ; Whitmore WF; Herr H; Sogani P; Morse M; Golbey RB
    J Clin Oncol; 1985 Mar; 3(3):336-9. PubMed ID: 2579214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The chemotherapy of nonseminomatous testicular tumors].
    Tiuliandin SA; Bulanov AA; Titov DA; Sokolov AV; Sholokhov VN; Garin AM
    Urol Nefrol (Mosk); 1996; (2):26-9. PubMed ID: 8677548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VAB-6 combination chemotherapy in disseminated cancer of the testis.
    Vugrin D; Herr HW; Whitmore WF; Sogani PC; Golbey RB
    Ann Intern Med; 1981 Jul; 95(1):59-61. PubMed ID: 6166230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VAB-6 combination chemotherapy in resected stage II-B testis cancer.
    Vugrin D; Whitmore WF; Herr HW; Sogani P; Golbey RB
    Cancer; 1983 Jan; 51(1):5-8. PubMed ID: 6185195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germ cell tumors (II): VAB II in metastatic testicular cancer.
    Cheng E; Cvitkovic E; Wittes RE; Golbey RB
    Cancer; 1978 Nov; 42(5):2162-8. PubMed ID: 82473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The results of the use of bleomycin and its analogs in the VAB-6 protocol in treating testicular tumors].
    Garin AM; Tiuliandin SA; Abdyldaev TA; Khlebnov AV; Kupchan DZ
    Antibiot Khimioter; 1988 Nov; 33(11):855-9. PubMed ID: 2465746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer.
    Vugrin D; Whitmore WF; Herr H; Sogani P; Golbey RB
    J Urol; 1982 Oct; 128(4):715-7. PubMed ID: 6183456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The VAB-6 regimen in the treatment of metastatic seminoma.
    Vugrin D; Whitmore WF
    Cancer; 1984 Jun; 53(11):2422-4. PubMed ID: 6201259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of VAB-6 combination chemotherapy on malignant germ cell tumours in childhood.
    Hayashi Y; Ohi R; Konno T; Tsuchiya S; Muraosa Y; Yaoita S; Watanabe T
    Z Kinderchir; 1989 Aug; 44(4):208-12. PubMed ID: 2477963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VAB-3 combination chemotherapy in primary mediastinal germ cell tumors.
    Vugrin D; Martini N; Whitmore WF; Golbey RB
    Cancer Treat Rep; 1982 Jun; 66(6):1405-7. PubMed ID: 6177411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
    Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
    J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.